CHEMBL4278686

hAChE (IC50 = 6.5 nM) and hGSK-3beta kinase activity (IC50 = 66 nM) hBChE (IC50 = 0.26 microM)

General

Type : GSK-3 kinase inhibitor, Derivative of Tacrine, Multitarget, Thiazole, Carboxamide, Pyridine, Cyclopropyl, Sulfur Compound

Chemical_Nomenclature : 2-[2-(cyclopropanecarbonylamino)pyridin-4-yl]-4-methoxy-N-[3-(1,2,3,4-tetrahydroacridin-9-ylamino)propyl]-1,3-thiazole-5-carboxamide

Canonical SMILES : COC1=C(SC(=N1)C2=CC(=NC=C2)NC(=O)C3CC3)C(=O)NCCCNC4=C5CCCCC5=NC6=CC=CC=C64

InChI : InChI=1S\/C30H32N6O3S\/c1-39-29-26(40-30(36-29)19-13-16-31-24(17-19)35-27(37)18-11-12-18)28(38)33-15-6-14-32-25-20-7-2-4-9-22(20)34-23-10-5-3-8-21(23)25\/h2,4,7,9,13,16-18H,3,5-6,8,10-12,14-15H2,1H3,(H,32,34)(H,33,38)(H,31,35,37)

InChIKey : XYSJVXMQSXKJCN-UHFFFAOYSA-N

Other name(s) : compound 2f [Jiang et al., 2018]  ||  dual GSK-3beta\/AChE inhibitor  ||  GTPL9810  ||  SCHEMBL23106153


MW : 556.7

Formula : C30H32N6O3S

CAS_number :

PubChem : 132427688

UniChem : XYSJVXMQSXKJCN-UHFFFAOYSA-N

Target

Families : CHEMBL4278686 ligand of proteins in family
ACHE

Protein :
human-ACHE

References (1)

Title : Dual GSK-3beta\/AChE Inhibitors as a New Strategy for Multitargeting Anti-Alzheimer's Disease Drug Discovery - Jiang_2018_ACS.Med.Chem.Lett_9_171
Author(s) : Jiang XY , Chen TK , Zhou JT , He SY , Yang HY , Chen Y , Qu W , Feng F , Sun HP
Ref : ACS Med Chem Lett , 9 :171 , 2018
Abstract :
PubMedSearch : Jiang_2018_ACS.Med.Chem.Lett_9_171
PubMedID: 29541355